Name (Synonyms) | Correlation | |
---|---|---|
drug2657 | Virtual-Care Cognitive Behavioural Therapy Wiki | 1.00 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This study will provide investigational convalescent plasma for patients infected with the SARS-CoV-2 with mild to moderate symptoms who meet inclusion criteria as judged by physician evaluation.
Description: a. Time to resolution of symptoms will be defined as time from randomization (day 0) to a successful outcome. c. A successful outcome is defined as symptom improvement of 3 numbers or down to zero on the memory aid for all symptoms noted.
Measure: Time to Resolution of Symptoms Time: 28 daysDescription: A 50% decrease at day 28 in C-Reactive Protein (mg/mL)
Measure: Decrease in Inflammatory Markers Time: 28 daysDescription: A 50% decrease at day 28 in D-Dimer (ng/mL)
Measure: Decrease in Inflammatory Markers Time: 28 daysDescription: A 50% decrease at day 28 in Ferritin (ng/mL)
Measure: Decrease in Inflammatory Markers Time: 28 daysDescription: A 50% decrease at day 28 in Lactate Dehydrogenase (U/L)
Measure: Decrease in Inflammatory Markers Time: 28 days